In mice with either B16F10 or CT26.CL25 tumors, splenocytes from PBT-treated mice demonstrated a significant increase in tumor-specific IFN-γ expression that was not present in tumor-bearing mice treated with DFMO or Trimer alone. The gene discussed is IFNG; the disease is neoplasm.